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Abstract 
The small intestine, which is lined by a single layer of intestinal epithelial cells, is the 
main site of nutrient absorption. It is continuously exposed to food antigens, and also 
several bacteria and microorganisms. Intestinal intraepithelial lymphocytes (IELs) are T 
cells that are interspersed between epithelial cells, above the basement membrane. This 
makes them one of the first immune cells to encounter and provide defence against 
invasive microbes. Studies have shown the important contribution of IELs patrolling 
along the epithelium to the immunosurveillance of the guts. However, little is known 
about how these immune cells move. 
Intestinal organoids are three-dimensional structures of epithelial cells that mimic the gut 
epithelium in vitro. In this study a murine IEL-organoid co-culture system was 
established to study IEL movement. It has been shown that it is possible to keep them 
together in culture for long-term and by performing brightfield and confocal microscopy 
imaging of the co-culture, I was able to visualize IEL movements. Indeed, IELs were 
observed to be highly motile inside organoids similar to previous studies. IL-15, a 
chemokine which is known to promote IEL proliferation and survival, can also affect IEL 
chemokinesis and chemotaxis. When IL-15 bindings was blocked, IEL movement was 
reduced. I also performed an analysis of IEL proteomic data for molecules regulated by 
IL-15 that could be involved in IEL migration. The expression of several adhesion 
molecules and chemokine receptors was either upregulated or downregulated which 
showed a potential involvement in IEL movement and retention within the epithelium. I 
showed that one way in which IL-15 drives IEL migration is potentially through a 
chemokine receptor, CXCR6. Results from the migration assay showed that IEL were 
chemoattracted and migrated towards CXCL16, the ligand of CXCR6. CXCL16 is 
expressed by stressed epithelial cells, and could be a mechanism for IELs to be attracted 
to sites of intestinal damage. 
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Introduction 
1. Intestinal epithelial cells and their roles in small intestine immunity
The small intestine is a part of the gastrointestinal tract, which is an organ that takes in 
food, digests it and absorbs nutrients. The lining of the gut consists of a single layer of 
intestinal epithelial cells (IEC), and their main function is to absorb nutrients from food. 
The epithelium also serves as a barrier that separates the lumen, which contains foreign 
substances accompanying the intake of food such as bacteria, and the sterile lamina 
propria which hosts several types of immune cells. Thus, its contribution to the gut 
immune system is highly significant.  
To aid in intestinal immunity, IECs serve two major functions: segregation and mediation 
(Okumura and Takeda 2017). Segregation is the separation of the gut microbes and host 
immune cells, while mediation is the delivery of signals between them. Both roles aim to 
maintain the balance between the intestinal microbiota and the host immunity, thus 
avoiding intestinal inflammation. IECs also generate two main types of barrier, physical 
barrier and chemical barrier. 
The physical barrier includes the mucus layer and epithelial layer. Mucus is a sticky fluid 
which is mucin-glycoprotein-rich. It forms a thick layer which covers intestinal epithelial 
cells. The epithelial layer is a single cell layer, composed mainly of enterocytes joined by 
tight junctions. It is a contiguous and relatively impermeable membrane, securely 
separating the sterile environment underneath the epithelium from foreign substances. 
The epithelium is organized into villi and crypts to increase the surface area (Fig 1). At 
the bottom of the crypts are pluripotent intestinal stem cells, which constantly generate 
new epithelial cells every 4 to 5 days (van der Flier and Clevers 2009). Differentiated 
cells, except Paneth cells, migrate upward and out of the crypts. Afterwards, epithelial 
cells undergo apoptosis and are shed off the villi into intestinal lumen, while new cells 
are constantly generated (Hall, Coates et al. 1994). As a result, the epithelium is always 
renewed (van der Flier and Clevers 2009). 
Secretory intestinal epithelial cells, which consist of enteroendocrine, goblet and Paneth 
cells, are specialized for maintaining the digestive or barrier functions of the epithelium 
(Peterson and Artis 2014). These cells secrete various gastrointestinal hormones, the 
mucus layer and antimicrobial peptides respectively. Microfold cells or M cells which 
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only found in the Peyer’s patches in the small intestine, are responsible for the uptake and 
delivery of antigens from the lumen to antigen-presenting cells (Mabbott, Donaldson et 
al. 2013). Tuft cells also contribute to intestinal immunity and are enriched in a G protein-
coupled receptor, SUCNR1 (succinate receptor) to sense protists and helminths which 
then can sufficiently activate type 2 inflammation (von Moltke, Ji et al. 2016, Ting and 
von Moltke 2019). Cup cells are another cell type which are randomly distributed in the 
villus epithelium and their function in gut immunity remains unclear (Madara 1982). 
To aid in the chemical barrier functions, Paneth cells produce antimicrobial peptides 
(AMPs) including the regenerating islet-derived 3 (Reg3) family of peptides that have a 
critical role in segregating bacteria from the epithelial surface of the small intestine 
(Okumura and Takeda 2017). AMPs are small, basic amino-acid-rich cationic proteins 
that can protect against bacterial infection by interacting with negatively charged 
microbial membrane, causing membrane disruption (Brogden 2005). The Reg3 family of 
proteins was defined as antimicrobial proteins of which Reg3γ is active against Gram-
positive bacteria (Cash, Whitham et al. 2006, Vaishnava, Yamamoto et al. 2011). The 
production of antimicrobial molecules by Paneth cells is regulated partially by 
Fig 1: The small intestine is organized into crypts and villi to expand the surface area of the gut. 
The epithelium is composed of several populations of specialized cells which contribute to the small 
intestine functions: absorbing nutrients and protecting the body from harmful components. Intestinal 





TLR4/Myd88 signalling and NOD2 signalling which is driven by gut microbiome 
(Vaishnava, Yamamoto et al. 2011, Muniz, Knosp et al. 2012).  
The intestinal immune system developed several tools in order to prevent the gut from 
bacterial invasion. The first one is the immunity provided by gut microbes. The intestinal 
microbiota has been indicated to be involved in the host immunity by constantly and 
directly contacting with host cells (Okumura and Takeda 2017). The second one is the 
protection from the epithelium composed by IECs. IECs can regulate host immune 
response by pro-inflammatory cytokine and chemokine secretion (Okumura and Takeda 
2017). For instance, in humans epithelium, TLR5/Myd88 signalling promotes IECs-
derived IL-8, which recruits neutrophils to the intestinal mucosa (Gewirtz, Navas et al. 
2001, Yu, Zeng et al. 2003). IECs also respond to bacterial substances by generating 
factors that enhance cell survival and repair, and immunoregulatory responses such as 
TGF-β (Bauche and Marie 2017). The third protective level is represented by the innate 
and adaptive immune cells: dendritic cells, macrophages, phagocytes and the 
lymphocytes that are observed scattering in the gut. The most abundant lymphocyte 
population in the intestinal epithelium is the intestinal intraepithelial lymphocytes (IELs). 
2. Intestinal intraepithelial lymphocytes 
IELs are one component of the intestinal immune system and are present an estimated 
density of one IEL for every 5 to 10 epithelial cells in the small intestine (Beagley, 
Fujihashi et al. 1995). IELs are interspersed between epithelial cells, above the basement 
membrane, which make them one of the first immune cells to provide defence against 
invasive micro-organisms (Hu, Jia et al. 2018). However, the understanding about how 
the IELs are fully activated and which factors drive the cytolytic activity of IELs toward 
infected cells remain unclear. 
Most of the IELs, around 90%, are TCR+ and can be further classified into induced and 
natural IELs, also known as conventional and unconventional T cells respectively. 
Induced IELs include CD4+ and CD8αβ+ TCRαβ+ subsets, derived from antigen-specific 
T cells that were activated in the periphery in response to antigens then enter the 
epithelium. Thus, they typically express a memory-like phenotype (Cheroutre, Lambolez 
et al. 2011). Natural IELs include TCRαβ+ and TCRγδ+ subsets, which enter the 
epithelium as soon as they are generated in the thymus, and typically express the CD8αα 
receptor (Van Kaer and Olivares-Villagomez 2018). Some natural IELs express natural 





Cheroutre, Lambolez et al. 2011). TCR-negative cells only account for 10% of IELs and 
consist of subsets that resemble to innate lymphoid-like cells (ILCs) found outside the 
intestinal epithelium.  
As the epithelium is constantly exposed to microbial pathogens and commensal 
organisms, IELs exert various functions in order to fight against bacterial and moderate 
overt inflammation (Sumida 2019). IELs can contribute to the innate immune response 
and fight against bacteria through cytolysis by secreting cytotoxic substances such as 
granzymes, perforin and Fas ligand or through natural killer receptors (Inagaki-Ohara, 
Nishimura et al. 1997, Bauer, Groh et al. 1999). Another mechanism is the regulation of 
mucus and antimicrobial peptides produced by Goblet cells and Paneth cells relatively 
(Hu, Jia et al. 2018). IELs are also involved in intestinal homeostasis and epithelial cell 
healing and repair (Cheroutre, Lambolez et al. 2011). For instance, TCRγδ+ IELs have 
the capacity to produce keratinocyte growth factor to regulate IEC integrity and healing 
(Boismenu and Havran 1994, Sheridan and Lefrancois 2010). IELs are known for their 
immunosurveillance at the epithelial layer to quickly respond to infection in the intestine 
(Van Kaer and Olivares-Villagomez 2018). So far, there have been several studies of IEL 
migration because such migration to site of infection provides efficient immune response. 
However, further investigation is still required to give an insight into the cellular 
mechanisms that regulate IEL migration at steady-state or in response to infection.  
3. Surface receptors on IELs involved in migration 
Unlike other lymphocytes, IELs do not recirculate, however, they express several 
chemokine receptors, including CCR2, CXCR3, CCR5 and CCR9. The process of 
recruiting natural IELs to epithelium, so-called IEL-homing was shown to rely on the 
interaction between CCR9 and its ligand CCL25 which presents on epithelial cells under 
homeostatic condition (Wurbel, Malissen et al. 2001, Uehara, Grinberg et al. 2002). In 
CCR9-deficient mice, approximately 2-fold of intestinal IELs diminished and this 
reduction mainly due to the loss of γδ IELs. In addition, the decrease in IEL number in 
the small intestine was found to depend on β7 integrin, another gut-specific homing 
molecule (Gorfu, Rivera-Nieves et al. 2009). Furthermore, other molecules were found 
to be involved in IEL recruitment to epithelium. CXCR3 is expressed on the surface of 
activated CD8+ IELs and is thought to activate these cells in response to pathogens 
(Strauch, Mueller et al. 2001). Lack of this molecule leads to change in the number of 
cells in each IEL subsets, thus, CXCR3 and its ligand CXCL10 are suspected to be 





noticeable chemokine receptor is CCR5 which is highly expressed by IELs. Its ligand is 
CCL5 which previously known as RANTES (Papadakis and Targan 2000). In CCR5-/- 
mice, there was increased inflammation and tissue damage upon Toxoplasma gondii 
infection (Luangsay, Kasper et al. 2003). Further, CD8β+ IELs isolated from CCR5 
deficient mice were impaired in their ability to migrate to infected tissues both in vivo and 
In vitro. CCL5 was shown to not have chemoattraction on primed IEL, instead it increases 
MIP-1α (CCL3) secretion (Luo, Berman et al. 2002). However, blocking CCL5 activity 
could totally inhibit migration of primed IELs to epithelial cells (Luangsay, Kasper et al. 
2003). Thus, the results suggested that CCL5 can mediate IEL migration through MIP-
1α and/or MIP-1β (CCL4) (both secreted by enterocytes) via chemokine receptor CCR5. 
In the same study, CCR2 expression level on primed IELs was found to be significantly 
lower than CCR5 and addition of an antibody to MCP-1, the CCR2 ligand, was ineffective 
to inhibit IEL migration. However, it is still a potential chemokine receptor to mediate 
IEL attraction.  
G protein-coupled receptors also play a role in IEL homing. GPR18 is expressed by 
CD8αα+ IELs and there is a reduction in CD8αα+TCRγδ+ IELs in mice lacking this 
receptor (Wang, Sumida et al. 2014). Another G protein-coupled receptor, GPR55 
negatively modulates accumulation of CD8αα+TCRγδ+ IELs. In addition, in GPR55-
deficient mice, IELs show faster movement and interact more with epithelial cells 
(Sumida, Lu et al. 2017). These results further confirm the involvement of chemokines in 
IEL migration. 
Fractalkine and its specific receptor CX3CR1 were reported to direct lymphocyte 
chemoattraction and adhesion within human intestinal mucosa (Muehlhoefer, 
Saubermann et al. 2000). This study showed that intestinal epithelial cells are a source of 
fractalkine and nearly half of the freshly isolated human IELs expressed the fractalkine 
receptor CX3CR1 on their surface (which contain approximately 80% CD8
+ IELs). 
Cultured human IELs were previously demonstrated to migrate to polarized intestinal 
layer in vitro (Shaw, Hermanowski-Vosatka et al. 1998). However, IELs need to be 
activated by IL-2R signalling in advance to migrate in response to fractalkine. This 
migration can partially be inhibited by pertussis toxin, suggesting IEL migration can 
potentially be regulated by chemokine receptor-mediated signalling (Shaw, 
Hermanowski-Vosatka et al. 1998). PTX is an exotoxin with an A-B structure that ADP-





et al. 1983). Previous studies also showed that PTX can inhibit the chemotaxis of 
neutrophils, lymphocytes and macrophages (Spangrude, Sacchi et al. 1985). IEL 
recruitment to the intestinal mucosa is also regulated by αEβ7 and fractalkine has been 
shown to mediate an integrin-independent adhesion in vitro (Imai, Hieshima et al. 1997, 
Haskell, Cleary et al. 1999), suggesting that fractalkine contributes to IEL retention 
within intestinal epithelial layer. In addition, fractalkine is strongly upregulated in the 
intestinal mucosa of patients with active Crohn’s Disease.  
Once IEL enter the epithelium, they interact with epithelial cells. Until recently it was not 
clear whether IEL moved between epithelial cells or stayed sessile. A study from 
Chennupati showed that IEL moved little while later studies showed that IELs were 
highly motile within the epithelium (Chennupati, Worbs et al. 2010, Hoytema van 
Konijnenburg, Reis et al. 2017, Hu, Ethridge et al. 2018) 
Crosstalk between IELs and IECs plays a key role in gut immune response (Hoytema van 
Konijnenburg, Reis et al. 2017). One factor involve in that interaction is occludin, a tight-
junction protein was reported to regulate TCRγδ+ IELs migration within epithelial layer 
(Edelblum, Shen et al. 2012). In occludin-deficient mice, TCRγδ+ IELs accumulation in 
intraepithelial compartment was impaired and IELs showed less interaction with IECs. 
This was only observed in TCRγδ+ IELs. Another molecule known to mediate the 
selective localization and retention of IELs is αE(CD103)β7 (Schon, Arya et al. 1999). 
This integrin is expressed in almost all IELs and its ligand, E-cadherin is found on 
epithelial cells and their binding mediates the adhesion of IELs to IECs (Cepek, Shaw et 
al. 1994). CD103 deletion increased migration of TCRγδ+ IELs to the lateral intercellular 
space (LIS) between epithelial cells, thus reducing pathogens invasion (Edelblum, Singh 
et al. 2015). When performing parallel transcriptome analyses in both TCRγδ+ IELs and 
IECs upon infection with Salmonella, there were an increase of Wnt/β-Catenin pathway 
which is responsible for the self-renewal capacity of intestinal stem cells (Hoytema van 
Konijnenburg, Reis et al. 2017). The Wnt/β-Catenin pathway also links with changes in 
IECs replacement rate, tissue regeneration and cellular metabolism (Karin and Clevers 
2016). Furthermore, enteric infection induced changes in TLR sensing and Myd88 
signaling, a pathway which IECs follow to response to pathogens (Hoytema van 
Konijnenburg, Reis et al. 2017). In Myd88-deficient mice, there was a loss of gene 
expressions associated with the immune response in isolated IECs and TCRγδ+ IELs. 





Altogether, IECs are possibly the first cells sense and response to microbes then 
communicate with IELs, and are also responsible for TCRγδ+ IELs behaviour regulation 
during infection in a Myd88-dependant way.  
An early study described the migration characteristics of TCRγδ+ IELs, which account 
for approximately 50 – 60% of IEL population in the murine small intestine (Chennupati, 
Worbs et al. 2010). They found that, under physiological conditions, intestinal TCRγδ+ 
IELs showed little movement and relatively confined to the epithelium. However, two 
later studies proved that under homeostatic conditions, IELs actively move in the space 
between the basement membrane and the epithelium, and occasionally show transient 
contact with epithelial cells (Edelblum, Shen et al. 2012, Hoytema van Konijnenburg, 
Reis et al. 2017). TCRγδ+ IELs showed a serpentine movement and a significant increase 
number of γδ IELs were found in the lateral intercellular space (LIS) upon infection with 
Salmonella enterica Typhimurium (Edelblum, Singh et al. 2015, Hoytema van 
Konijnenburg, Reis et al. 2017). In addition, TCRγδ+ IELs were observed to gather near 
and directly contact with infected cells which would enable these cells to protect the host 
and provide a quick response against pathogens. Thus, TCRγδ+ IELs patrol the 
epithelium and migrate between adjacent epithelial cells to do their protective functions 
and without TCRγδ+ IELs, enteric pathogen invasion increased (Edelblum, Singh et al. 
2015). Therefore, IELs behavioral changes possibly depend on gut infection and direct 
contact with bacteria is required for them to fight against bacteria. However none of these 
studies have evaluated the movement of TCRαβ+ IELs. 
4. Intestinal organoids 
As mentioned above, it is shown that IEL migration and close interaction with IECs play 
an important role in gut immune response, thus IECs might be involved in IEL migration. 
However, studying interactions of IELs with IECs is challenging as isolated IECs easily 
undergo a programmed cell death, termed anoikis – a form of apoptosis (Frisch and 
Francis 1994). Recent advances allow long-term culture IECs as organoids, a culture 
system derived from intestinal stem cells (ISCs) (Sato, Vries et al. 2009). 
An organoid is a three-dimensional structure which can resemble cellular composition 
and tissue organization of the intestine (Sato, Vries et al. 2009). As mentioned above, 
intestinal stem cells (ISCs) are located near the crypt bottom, at a density of 4 to 6 cells 
per crypt. ISCs produce the transit amplifying (TA) cells, which can proliferate rapidly. 





migrate upwards along the crypt-villous axis. Paneth cells – secretory cells that secret 
Wnt3a, stay at the bottom of the crypts. According to this breakthrough study, intestinal 
organoids can be formed by supplementing ISC essential growth signals. First, Wnt 
signalling was reported to be a pivotal element for crypt proliferation (Pinto, Gregorieff 
et al. 2003). A Paneth cell then emerged, representing the first symmetry-breaking event 
in intestinal organoid formation (Serra, Mayr et al. 2019). A Wnt3a gradient is formed 
around these cells and is believed to determine a crypt site. In addition, Wnt agonist, R-
spondin-1 also induced crypt hyperplasia in vivo. Second, epidermal growth factor (EGF) 
was associated with intestinal proliferation by reducing TGFβ-induced inhibition of IEC 
proliferation (Kurokowa, Lynch et al. 1987, Dignass and Sturm 2001). Third, crypt 
number expansion was reported to depend on transgenic expression of Noggin (Haramis, 
Begthel et al. 2004). The last element was Matrigel, a mixture of extracellular base matrix 
to support intestinal organoid growth which have been applied to grow the epithelium of 
mammal (Stingl, Eaves et al. 2001). Laminin is also an enriched element at the crypt base, 
thus the use of Matrigel is to create an environment that mimics the stem cell niche in 
vivo (Sasaki, Giltay et al. 2002).  
In vitro culture of intestinal organoids, also known as enteroids, with supplementation of 
all the growth factors above enables a long-term survival of enteroids and a reminiscent 
of normal intestine. There is a crypt-like structure with Paneth cells reside at the bottom 
 
Figure 2: Bright field microscopy of a mouse small intestinal organoid with crypt domains (red 
bracket) and villus domain (black bracket). Paneth cells are presented at the crypt domain (black 
arrow). The lumen is filled with dead cells. Organoids were cultured with supplementation of EGF, 






and TA cells. This crypt region is where the budding events occur. Budding events are 
similar to crypt fission which is a process in intestinal epithelium expansion (Langlands, 
Almet et al. 2016). There is also a villus-like domain composed of enterocytes. Apoptotic 
cells are shed off into the lumens and this process is similar with the dead cell shedding 
event in normal gut (Fig 2). In addition, IECs expanded by this method can reconstitute 
normal epithelium when being transplanted back into syngeneic mice, showing that the 
in vitro culture of IEC does not affect the conservation of their in vivo features (Nozaki, 
Mochizuki et al. 2016). 
5. Co-culturing IEL with organoids 
IELs are highly susceptible to apoptosis after isolation, thus, it has been a challenge to 
study IEL functions and behaviours in vitro. However, survival and proliferation factors 
derived from IECs can support the maintenance of IEL in vitro (Nozaki, Mochizuki et al. 
2016). This suggested that IECs have physiological properties that provide a suitable 
microenvironment for a sustained culture of IELs. Isolated IEC also easily undergo 
anoikis (a form of apoptosis), but recent advances allow long-term culture of IEC as 
enteroids, three-dimensional primary culture systems that are derived from intestinal stem 
cells.  
A co-culture system of IELs and intestinal organoids has been developed to study in vitro 
IELs interaction with IECs (Nozaki, Mochizuki et al. 2016). In this study, exogenous 
addition of cytokines, IL-2, IL-7 and IL-15 were used to test their effects on IEL 
maintenance and all three were able to expand IEL and maintain IEL survival. IELs were 
shown to move around enteroids with high motility and constantly changing their contact 
with enteroids. Some IELs approached enteroids, stayed in it and then egressed from it; 
others got into enteroids and moved along the epithelial layer in a random direction. 
Enteroids also support IELs proliferation and IELs have been observed to behave 
normally inside enteroids. Another group also utilised this method to co-culture TCRγδ+ 
IELs with enteroids derived from WT mice in order to study the importance of IL-15 (Hu, 
Ethridge et al. 2018).  They performed an intravital microscopy on WT mice and mice 
with IL-15 overexpression in the epithelial layer found that in those overexpressing 
murine IL-15, the number of TCRγδ+ IELs associated with enteroids and migrating to 
the lateral intercellular spaces was increased. IL-15 has been shown to promote IEL 
survival and proliferation through the trans-presentation of IL-15 by epithelial IL-15Rα 





receptor IL-15Rα and IL-2Rβ-deficient mice (Suzuki, Duncan et al. 1997, Lodolce, 
Boone et al. 1998, Ma, Acero et al. 2009). Thus, epithelial IL-15 could be a 
chemoattractant for IEL migration. These studies showed that the IEL-organoid co-
culture system can be an efficient tool to study the dynamic nature of IELs. However, 
very little is known about what controls their migration, their migration is directional or 
non-directional, there is so much still need to be learned in this area that my project will 
explore.  
6. Project objectives 
The main aims of the projects are: 
 Establish a stable co-culture between mouse-derived IELs and enteroid. 
 Visualize and measure IEL movement by widefield and confocal live imaging of 
the co-culture. 
 Identify potential molecules and determinants involved in the regulation of IEL 




















1. Studying IEL movement in organoids 
The first aim of my project was to develop a stable co-culture between IEL and 
enteroids. I first tested different available media used for enteroid culture to select 
which medium will be appropriate and best support both IEL and enteroid growth. With 
this system, I could further study the IEL migration in enteroids by performing live 
imaging. 
1.1. Testing organoid cultures in different media 
Because most of our experiments were dependant on robust intestinal organoid cultures, 
it was important to find the best conditions to culture them. To that end, the whole 
intestinal tissue preparation was performed on ice to preserve the yield of crypts. 
Following the protocol, after a vigorous shake for one minute, a mixture of villus and 
crypts were obtained as demonstrated below (Fig 3). 
For enteroid culturing, I tested three different medium formulations available: ENR (Sato, 
Vries et al. 2009), OGM (a commercial organoid growth medium from Stem Cell 
Technologies) and conditioned L-WRN medium (Miyoshi and Stappenbeck 2013). ENR 
is a basic crypt medium supplemented with organoid growth factor EGF, R-spondin and 
Noggin. After one to two days in culture, three dimensional structures were visible.  
 






Crypts grown in ENR (Fig 4A) developed budding structures approximately 3 to 4 days 
after culture. It was similar to what I observed with crypts cultured in OGM, the 
commercial organoid media. A third medium is conditioned L-WRN media. This medium 
is produced from an L cell line which was engineered to secrete Wnt3a, R-Spondin-3 and 
Noggin into the medium (Miyoshi and Stappenbeck 2013). Crypts cultured in this 
conditioned medium formed nearly spherical, non-budding three-dimensional structures, 
known as spheroids (Fig 4B). Spheroids are highly enriched for proliferating cells, so 
they expand rapidly. These spheroids started to become visible after just one or two days 
in culture then quickly developed in size and needed to be passaged after 3 to 4 days (Fig 
4B). L-WRN media could be replaced with ENR or OGM after the first passage, we then 
observed the budding structures in 3 to 4 days after switching to ENR and OGM. 
Therefore, I was able to identify L-WRN conditioned media as the most suitable medium 
to promote the formation and proliferation of enteroids which should be used in the first 
4 to 5 days. Then ENR or OGM can be used to differentiate and maintain the proper 
epithelial structure and morphology of the enteroids. 
1.2. Establishing the IEL-enteroid co-culture 
The next step in the project was to establish a sustainable co-culture in which both 
enteroids and IELs are healthily growing during the length of experiment, which can up 
to two weeks. The protocol was followed based on Nozaki et al, 2016. Briefly, enteroids 
were passaged or cultured two days prior to the co-culture with IELs. When enteroids 
were passaged, debris which accompanying the crypts in the isolation process would be 
get rid of, thus passaged enteroids were preferred in my experiment. On the day of the 
co-culture, IELs were isolated and sorted for CD8-positive cells, the sorting was ensured 
of 90% purity (by flow cytometry). Enteroids were counted before releasing from 
 
Fig 4: Mouse small intestinal enteroids after 3 – 4 days in culture. A) Enteroids cultured in ENR 
developed into budding structures. B) Enteroids grew into spheroids when cultured in L-WRN 
media. C) Enteroids cultured in OGM also have a budding structure, similar to ENR, these enteroids 






Matrigel by washing the well with cold Advance DMEM/F12 media. Enteroids were 
disrupted by pipetting vigorously. IELs and enteroids were mixed together with a ratio of 
1 enteroid and 500 IELs, warm medium was added, and the mixture was incubated for 30 
minutes. Subsequently, the pellet was collected and suspended in Matrigel before adding 
to a 24-well plate. For this, I used ENR or OGM to develop budding structures. As IL-15 
and IL-2 are known to support the proliferation of IEL, they were added to the medium 
at a concentration of 10ng/mL and 100U/mL respectively (Nozaki, Mochizuki et al. 
2016). In these conditions, I was able to maintain a viable co-culture for 12 days. In order 
to track IELs, I isolated IELs from mice expressing a robust tdTomato fluorescent reporter 
following GranzymeB-Cre-mediated recombination in IELs. IELs appeared to get into 
the enteroids right after plating and after 4 days of being co-cultured, almost all IELs 
moved into enteroids (Fig 5). At day 1, as shown by the figure, there were a total of 55 
IELs and 11 of them were inside enteroids; while at day 4, there were 43 IELs and 39 of 
them were inside enteroids. IEL number reduction would be a result of cell death.  
After passaging, IELs were still alive and remained inside the enteroid, indicating that 
enteroids provided a suitable and essential microenvironment for them to grow. The 
extrinsic IL-15 added into the medium was believed to support the survival of IELs 
outside enteroids in the Matrigel.  
 
Fig 5: IEL-organoid co-culture establishment. Bright field and merge images showed IEL migration 
into enteroid after a day and 4 days of plating. IELs were isolated from a td-tomato mouse of which 






1.3. IEL movement both inside and outside organoids 
Now that I had established the co-culture, the next step was to study how IEL moved into, 
and within the enteroids. To study the movement of IEL in the co-culture, I performed 
live imaging with widefield fluorescent microscopy and confocal microscopy. I did the 
live imaging at day 2 after plating to observe IEL movement both inside and outside 
enteroids. IELs in Matrigel could be seen moving into the enteroids (Fig 6). Inside the 
enteroids, by tracking IELs movement, I was able to determine that IEL were moving at 
the speed of 0.1 microns per sec (Fig 7), which approximately similar to those reported 
in Nozaki et al, 2016. Interestingly, some IELs appeared to move from one enteroid to 
another. I also noted the presence of IEL which were immobile in the beginning and then 
started moving following no specific direction. It should be noted that tracking the 
movement of IELs was difficult since the live imaging was done with a 3D structure, it 
can be interrupted when IEL were out of focus and disappeared from the plane of view. 








Fig 6: Visualize IEL motility in co-culture using confocal microscopy, supplemented with ENR 
medium. A figure showed the tracking movement of IELs in the co-culture. Three IELs at the top of 
the region were moving outside enteroids. Two IELs (white arrow) were moving along the outer 









1.4. Investigating the importance of IL-15 in IEL migration 
Our results so far indicate that IEL are highly motile inside the enteroids, confirming 
recent in vivo data showing that TCRγδ+ IEL were moving within the intestinal mucosa 
(Hu et al, 2018). This indicates that our IEL-enteroids co-culture is a good model to study 
IEL movement. IL-15 is known to promote the proliferation and survival of IELs and the 
trans-presentation of IL-15 by epithelial IL-15Rα to IL-2Rβ expressed on T cells is 
required (Ma, Acero et al. 2009). IL-15 was stated to be a critical regulator of TCRγδ+ 
IELs as IL-2Rβ inhibition by a blocking antibody (TM-β1) significantly reduced IEL 
speed and displacement length after 48-hour treatment (Hu, Ethridge et al. 2018). We 
wanted to see in our co-culture system, if inhibition of IL-15 signalling would result in 
any changes in IELs movement. To do so, I set up a co-culture between IELs and enteroids 
as previously described with IL-2 and IL-15 supplementation, this condition also used as 
controls. I then treated the IEL-enteroid co-cultures with 40µg/ml of TM-β1, an anti-IL-
2Rβ blocking antibody at two timepoints, 1 hour and 48 hours before imaging. IELs 
treated with the IL-15 alone moved frequently over the course of the live imaging. 
 
Fig 7: IEL were highly motile in co-culture. The live imaging was done with the widefield 
fluorescent microscopy. Three IELs were spotted at the ROI. The lines showed the distance of target 
spots and they were not seamless due to IELs moving out-of-focus and each color showed a different 





However, 48h treatment of TM-β1 lead to a significant decrease in displacement length 
compared with controls. Within 1h of TM-β1 treatment, the effect of IL-2Rβ inhibition 
on IEL migration was evident with respect to the number of IEL moving during the 
imaging. All IELs observed within the enteroid and were highly motile. In the 1h TM- β1 
treatment, there were 5 out of 14 IELs did not move, 2 of them were outside enteroids; in 
other region, 6 out of 20 IELs detected were not motile and all of them were outside 
enteroid. In 48h TM- β1 treatment, all of the IELs were inside and moving within 
enteroids. Thus, with TM-β1 treatment, more IELs seemed to idle and this was more 
likely to happen to IELs in the Matrigel than those within enteroids. 
There was a clear reduction in IELs speed between TM-β1 treatment and control in one 
experiment (Fig 8), however this decrease was not reproduced in the second experiment 
(data not shown). It appeared that IEL speed in the control conditions was lower than that 
in TM- β1 treatment condition in my second experiment. This could be explained by the 
increase in the number of sessile IEL per region of interest observed, longer imaging time 
and the fact that there were more idle IELs even in the control. IELs which were already 
inside enteroids seemed to be more active than IELs in the Matrigel. Despite these 
caveats, blocking IL-2Rβ still reduced the track displacement length in this experiment 
 
Fig 8: IL-2Rβ inhibition decrease IEL kinetics in co-culture. Mean track speed and displacement 
length of IEL in co-culture with TM-β1 treatment for 1h or 48h before imaging. Number of tracks: 
n = 77, 31 and 8, corresponding to the condition presented on the graph). Tracks were generated 
from time-lase imaging acquired every 2.5 minutes for 105 minutes. Image data was analysed by 
Imaris and data was shown as individual spot for non-normal distributed data. Statistics done with 






as well. Therefore, we were able to conclude that IL-2Rβ inhibition had a negative effect 


























2. Molecular determinants involved in IEL intraepithelial migration 
We established a co-culture system between IELs and enteroids and used it to visualize 
and study the impacts of IL-15 inhibition on IEL movement in enteroids. My next aim 
was to investigate the involvement of any potential molecules such as adhesion 
molecules or chemokine receptors in IEL migration and retention within the epithelium. 
To this end, I first analysed the proteomic data of three IEL subsets after 24-hour IL-15 
exposure which has recently established by our laboratory. Then, by performing 
migration assay, I tested IEL response to CXCL16, a ligand to CXCR6 which is a 
chemokine receptor expressed on IELs and is upregulated by IL-15. 
2.1. Analysis of IEL proteomic data for molecules regulated by IL-15 involve in 
IEL migration 
As stated above, we observed a reduction in IEL movement in vitro as a response to TM-
β1 treatment, suggesting IL-15 might be important for IEL migration. However, previous 
study (Hu, Ethridge et al. 2018) suggested that IL-15 does not function as a chemotactic 
agent for IELs albeit that it can increase chemokinesis. The difference between 
chemokinesis and chemotaxis is the direction of movement; chemokinesis is the 
movement in any direction while chemotaxis the movement towards an attractant. 
Therefore, I wanted to address if IL-15 regulates the migration of IEL through other 
molecules. Our laboratory has recently developed a proteomic map of the global changes 
induced by IL-15 in IEL. Thus, I analysed this data set to identify proteins regulated by 
IL-15 that might play a role in IEL migration. 
Quantitative label-free mass spectrometry was performed on the three main IEL 
subpopulations, TCRγδ CD8αα, TCRαβ CD8αα and TCRαβ CD8αβ after 24 hours 
exposure to 100ng/mL complexed IL-15 (assigned as high levels of IL-15). IELs isolated 
directly ex vivo were used as untreated controls (James, Vanderyken et al. 2020). More 
than 7100 proteins were identified and quantified in all three subsets. Proteins with a fold 
change >2 were considered as upregulated, whereas proteins with a fold change <0.5 were 
downregulated, and the rest were considered unchanged by IL-15 stimulation. Since the 
error bar of the standard deviation is large due to the inherent issues of label-free 
proteomic quantitation, we did not consider the statistical significance value, however, 
we focussed on proteins which had been quantified based on at least two peptides being 
identified by mass spectrometry, and that were found in at least two replicates (out of 





focused only on the upregulated and downregulated proteins that are expressed at the cell 
surface, as indicated by Uniprot. This would help us to confirm its involvement in IEL 
migration quickly by adding blocking antibodies. We further narrowed down the number 
by selecting proteins that are involved in cell adhesion, cell chemotaxis and migration. 
These analyses lead to a list of 74 upregulated and 26 downregulated potential proteins. 
In order to corroborate proteins involved in adhesion, migration and chemotaxis, I also 
used the functional annotation clustering from DAVID database 
(https://david.ncifcrf.gov/tools) to select the proteins whose topological domains are 
extracellular; involved in cell-cell adhesion, cell migration and chemotaxis. The 
commonly identified proteins between the two analyses are presented in Table 1 
(Appendix). 
Among the upregulated proteins, common chemokine receptors such as CXCR6, 
CXCR3, CCR9 and CCR5 were detected (Fig 9A). These receptors are all chemokine 
receptors, involved in cell chemotaxis. CXCR6 functions have not been previously 
studied on IEL. CCR5 and CXCR3 have been shown to be expressed on all human and 
murine IEL (Agace, Roberts et al. 2000). CCR5 is implicated in the migration of IEL 
 
Fig 9: Bar graph shows protein copy numbers upregulated by IL-15 of A) Chemokine receptors.  
B) Adhesion molecules C) Activating receptors. All of these molecules have been quantified in 
at least two peptides of at least two replicates (out of four). Fold changes of these molecules 





towards T. gondii infected cells. CCR5 expression was increased in TCRαβ CD8αβ but 
decreased in TCRγδ CD8αα and unchanged in the other subset, suggesting potential 
different impacts of CCR5 in different IEL subsets (Fig 9A). CCR9 as previously 
mentioned in the introduction, has important contribution to the IEL homing to the gut. 
There were a few adhesion molecules like L1CAM, PECAM-1, ICAM-2 and ALCAM 
which were reported to play a role in adhesion of platelet/endothelial cells, neuronal cells 
and activated leukocytes (Fig 9B). The upregulation of these molecules in all three IEL 
populations after culturing with IL-15 suggests its involvement in IEL trafficking.  
Activating receptors like JAML and CD226 were upregulated and involved in cell-cell 
adherence junctions (Fig 9C). CD226 is a member of the poliovirus receptor (PVR)-
nectin family, an activating and natural cytotoxic receptor that activates NK cells and 
regulates its response against tumours (Shibuya, Campbell et al. 1996, Du, de Almeida et 
al. 2018). CD226 also mediates cell-cell adhesion through binding with its ligands, 
CD112 and CD155 (Bottino, Castriconi et al. 2003, Tahara-Hanaoka, Shibuya et al. 
2004). TGF-β (transforming growth factor beta) is secreted by IELs to maintain intestinal 
homeostasis (Konkel and Chen 2011) and its receptor type 1 and 2 were found to be 
strongly upregulated in IELs after exposing to IL-15.  
Noticeable among the downregulated proteins were Cadherin-17 (Cdh17), a calcium-
dependent transmembrane glycoprotein that concentrates in adherence junctions in IECs 
and plays a critical role in intestinal homeostasis by limiting epithelium permeability 
(Wendeler, Drenckhahn et al. 2007, Chang, Yu et al. 2018) (Fig 10). Integrin alpha M 
was downregulated suggesting IEL adherence was partially integrin mediated. Apart from 
the cell surface proteins, a cytoplasmic protein, regulator of G-protein signalling RGS1 
expression was also decreased. This protein is interesting because RGS proteins are 
 
Fig 10: Bar graphs shows protein copy numbers downregulated by IL-15. Cdh17 and ItgaM are 
involved in tight junction and cell-cell adherence. CCR5 is a chemokine receptor. Fold change of 





GTPase activating proteins and RGS1 is highly expressed in lymphoid organs and acts as 
a negative regulator of chemokine receptor signalling in lymphocytes (Reif and Cyster 
2000, Moratz, Harrison et al. 2004). This observation raised a hypothesis that high-level 
IL-15 culture might down-regulate adhesion protein expression and increase the ability 
of IEL moving under chemokine signalling, thus will lead to IEL moving more freely 
within the epithelium. The expression of some proteins in TCRαβ CD8αβ subpopulation 
is different from the other two (e.g CCR5, RGS1), indicate other mechanisms may 
regulate the migration in this induced IEL population. 
2.2. Investigating the role of CXCR6 in IEL migration 
As CXCR6 is the chemokine receptor that has not been implicated in IEL biology, we 
further investigate the role of CXCR6. CXCR6 is interesting as it possibly acts as both an 
adhesion and chemotactic molecule and it is responsible for the retention and circulation 
of innate lymphoid cell precursors (Chea, Possot et al. 2015, Koenen, Babendreyer et al. 
2017). CXCR6 is expressed by subsets of CD4+ T cells, natural killer (NK) cells, NK T 
cells and plasma cells (Deng, Chen et al. 2010). CXCR6 also involved in recruitment of 
several immune cells (Butcher, Wu et al. 2016, Ashhurst, Florido et al. 2019). However, 
its role on IEL has not been studied. First, I checked CXCR6 expression on ex vivo IELs 
and 24-hour cultured IELs with high level of IL-15. I used splenic T cells as a negative 
 
Fig 11: CXCR6 expression in three main IEL subsets. Ex vivo and 24-hour cultured with 100ng/mL IL-
15 IEL were stained for CXCR6. Splenic T cells were used for negative control. A) Histogram showed 
CXCR6 expression in spleen T cells (red), ex vivo IELs (blue) and 24-hour cultured IELs (orange) of 
three IELs populations. B) Bar graphs showed the MFI of CXCR6 in spleen T cells, ex vivo IELs and 





control since CXCR6 is expressed on these cells at a low level (Matloubian, David et al. 
2000). Clearly, IELs express CXCR6, and this is further upregulated after culture. Figure 
11A showed an upregulation of CXCR6 expression comparing to the ex vivo and splenic 
T cells.  
Next, we wanted to test if IL-15 regulates IELs migration through CXCR6 expression by 
a Transwell migration assay. I used CXCL16, the only known ligand for CXCR6 as a 
chemoattractant. CXCL16 has been found to be expressed by macrophages, dendritic 
cells, epithelial cells (Matloubian, David et al. 2000, Agostini, Cabrelle et al. 2005). 
Briefly, IELs were isolated and cultured with 100ng/mL IL-15 to upregulate CXCR6. 
After 24 hours of incubation, approximately 500,000 IELs were plated into the Transwell 
insertions, and CXCL16 was added together with medium to the bottom chamber. First 
thing I observed after incubation time of 1h30 was that IEL had migrated to the bottom 
in every well (Fig 12). However, there was a significant difference between two 
conditions: with and without chemokine addition. This suggested that IELs can migrate 
in response to the gradient of CXCL16. The addition of IL-15 into the cells did not make 
any significant difference which indicate that IL-15 did not accelerate the migration of 
IEL, consistent with the previous result from a lab member that CXCR6 was expressed 
even when cultured with low level of IL-15 (2ng/mL) and at the equivalent level with 
 
Fig 12: In vitro migration assay in the presence or absence of CXCL16. IELs were isolated, sorted for 
CD8+ T cells and cultured with 100ng/mL IL-15Rα for 24 hours. IELs were collected and washed twice 
then plated into Transwell inserts, CXCL16 (10ng/mL) and IL-15Rα (100ng/mL) was added to the 
medium at the bottom. Whole co-culture was incubated for 1h30min. After incubation, IELs at the 
bottom were quantified. Experiments were done three times independently and each condition was 
repeated triplicate. Data was shown as percentage of migrated cells relative to number of cells added in 
each experiment. Data was analysed using one-way ANOVA test with multiple comparisons to control 





100ng/mL of IL-15 (data not shown). These data showed that CXCR6 was expressed in 
cultured IEL and cultured IELs were chemoattracted by CXCL16. Together, CXCR6 
upregulation by IL-15 is involved in IEL migration.  
To further address the roles of chemokine signalling pathway on IEL movement, I did an 
IEL-organoid co-culture as previously described with Pertussis toxin. Pertussis toxin 
inhibits a majority of chemokine receptors thus inhibit migration of several cells like 
neutrophils and lymphocytes as mentioned in the introduction. Here I used 10ng/mL 
Pertussis toxin added in the medium, a concentration when cell migration was shown to 
be inhibited (Gilder, Wang et al. 2016). As shown in figure 13, at day 2 after plating, there 
were more IEL migrated into organoids in the control than when Pertussis toxin was 
added. This was also observed at day 4 of the co-culture. By counting the number of cells 
in all regions of interest, at day 2, there were 20% of the IELs outside of enteroids in the 
control while with PTX treatment, the percentage was nearly 60%. At day 4 of the co-
culture, due to the autofluorescent of the dead cells, it was difficult to count the cells but 
I can still observe there were no IELs outside enteroids in the control, and there were still 
a few IELs outside enteroids with PTX treatment. The reduction of free IELs outside 
enteroids might also indicate cell death over time. Despite that, I was able to observe that 
the number of IELs moved into organoids was less with the pertussis toxin addition. It 




Fig 13. IEL-organoid co-culture with PTX treatment. IEL-organoid co-culture was established as 
described, supplemented with 100U/mL IL-2 and 10ng/mL soluble IL-15 as controls; to inhibit 
chemokine receptors, 10ng/mL pertussis toxin was added in the medium. Photos were taken at day 2 
and day 4 after plating. The first row was the control (CT) and the second row showed the co-culture 







There have been several studies about IEL migration as IEL patrolling along the 
epithelium plays a key role in the intestinal immunosurveillance of immune cells. Despite 
its importance, little is known about the mechanism that regulate IEL motility within 
epithelial compartment. One study has shown that epithelial IL-15 is a critical regulator 
for the migration of γδ IELs into the epithelium. However, IL-15 is only sufficient to 
affect IEL chemokinesis. Co-culture between IEL and intestinal organoid was a suitable 
system to study the IEL intraepithelial movement as intestinal organoid has been shown 
to provide a microenvironment that sustains IEL survival in vitro. Thus, I wanted to 
investigate in more detail how IEL motility was regulated within the epithelium using this 
co-culture system.  
In my project, I successfully established long-term IEL-enteroid co-cultures that could be 
used for the study of IEL intraepithelial movement. I tested three different media for 
enteroid culturing. L-WRN conditioned medium was used to facilitate the proliferation 
process to rapidly develop the number of spheroids. Epithelial cells grown in L-WRN 
conditioned media, developed into spheroids which are spherical in shape and have thin 
outer walls. Since IEL interacted with more differentiated enterocytes, I switched to 
medium containing R-Spondin-1 (instead of R-Spondin-3), Noggin and EGF, without 
Wnt3a (ENR), or OGM to obtain a budding structure of differentiated organoids. I also 
tested these media for the study of IEL motility in the co-culture. Generally, I observed 
that there were less IELs migrated into spheroids than differentiated organoids (data not 
shown). IEL might prefer intestinal organoids with budding structures as they resemble 
the structure of the gut in vivo and the outer wall of enteroids were similar to the epithelial 
layer where IELs reside. In addition, since differentiated enteroids mimic the 
microenvironment of the gut, it can produce some cytokines or growth factors that are 
favourable to IELs. In contrast, spheroids have thinner outer walls which can hardly 
support IEL retention. They are composed of mainly progenitor cells, thus, growth factors 
and signalling molecules secreted might be suitable for spheroid proliferation but not 
IELs. A former lab member showed that there were no significant difference in IEL 
survival with the addition of IL-7, thus for my co-culture, I only used IL-15 and IL-2 to 
support the survival of IELs.  Further, IELs might respond to the endogenous IL-15 





spheroids can produce. Therefore, we focussed on using differentiated organoids in ENR 
media for co-culture with IEL.  
I could also show that the co-culture model was a good model to study IEL intraepithelial 
movement as IELs were highly motile in my experiments. I observed  a slight reduction 
in the number of IELs after few days in co-culture, which probably cell death, but I was 
not able to measure the rate of cell death over time. Despite that, the avarage speed of 
IELs was approximately similar to that seen by Nozaki et al (Nozaki, Mochizuki et al, 
2016). In vivo movement of IELs were measured to be at 3 - 8µm/min (Edelblum, 2015). 
It can also be used to test the functions of surface receptors or proteins that might involve 
in IEL migration by adding blocking antibodies. However, to visualize IEL behaviours 
within enteroids under infection, bacteria needs to be microinjected into enteroids which 
makes it more complicated.  
As we have established a co-culture system which we can use to observe IEL movement, 
we then investigated any factors might involve in IEL movement. IL-15 was previously 
shown to regulate TCRγδ+ IELs motility within the intestinal mucosa in vivo and in 
enteroid co-cultures (Hu, Ethridge et al. 2018). I also found that the mean displacement 
length and mean speed of IEL movement within enteroids were reduced by treatment with 
an antibody which inhibits the binding of IL-15 with its receptor. However, tracking the 
movement of IELs is challenging as organoids have a three-dimension structure and IELs 
might move out of focus thus the track displaement length might not express the real 
replacement of IELs. Also, I was not able to separate the data of IEL movement within 
and outside enteroids. Furthermore, the number of enteroids was approximated and the 
distribution of organoids and IELs when plating was inevitably uneven. Another caveat 
of my study was that TM-β1 blocks the IL-2Rβ chain, which is used by both IL-2 and IL-
15. There have been no studies of IL-2 effects on IEL migration, however IL-2 was added 
in both the controls and TM-β1 treatment. Thus, I can conclude that blocking IL-2Rβ 
affects IEL movement in vitro which was consistent with the observation from previous 
study, which implied that either IL-2 or IL-15 signals are needed for IEL migration.  
In addition, I showed that cultured IELs could migrate along a chemotactic gradient of a 
chemokine, CXCL16. The proteomic data indicated that CXCR6 were upregulated in all 
three IEL subpopulations after 24 hours exposure to IL-15, and I confirmed these data by 
flow cytometry. CXCL16 was shown to strongly induce a chemotactic migration of 





receptors expressed on the cells (Matloubian, David et al. 2000). It could explain the 
higher number of IELs migrated to the bottom of the plate with the presence of CXCL16 
based on the high expression of CXCR6 on cultured IELs. There was no significant 
difference in the number of IELs migrated when IL-15 was added to the cells, indicating 
that IL-15 was not directly affecting IEL chemotaxis, but indirectly through the 
expression of chemokine receptors, in this case CXCR6. CXCL16 is expressed by 
intestinal epithelial cells, suggesting that the interaction between CXCR6 on IELs and 
CXCL16 on epithelial cells might contribute to IEL migrate to and retaining in the 
intestinal epithelium (Diegelmann, Seiderer et al. 2010). Matsumura et al. showed that 
ionizing radiation can enhance CXCL16 production by mouse and human breast cancer 
cells, which can recruit other anti-tumour CXCR6-expressing cells (Matsumura, Wang et 
al. 2008). A study from Diegelmann showed CXCL16 stimulates the activation of several 
signaling pathway such as ERK-MAP and Akt kinase (Diegelmann, Seiderer et al. 2010). 
The mRNA and protein expression of CXCL16 were increased by proinflammatory 
stimuli and upon intestinal inflammation, suggesting the critical role of CXCL16 in 
mucosal innate and adaptive immune response regulation (Diegelmann, Seiderer et al. 
2010). CXCR6 functions on IELs indeed needs to be investigated as it might suggest 
novel insights about IEL-IEC interaction, how it contributes to IEL immunosurveillance 
of the gut and provide new strategies in intestinal cancer treatments.  
The functions of chemokine receptors affected by IL-15 in the proteomic data were 
previously described in the introduction. Among them, CXCR6 was studied in my project 
and it showed that CXCR6 involved in IELs migration. In addition, with the treatment of 
Pertussis toxin, which blocks signalling of a major chemokines, strongly inhibited 
lymphocytes migration (Spangrude, Sacchi et al. 1985). Indeed, treatment of IEL-enteroid 
co-culture with Pertussis toxin has shown inhibited  IEL migration into enteroid. Further, 
I observed by live imaging that there were less IELs moving in and out of enteroid in co-
culture when Pertussis toxin was added in the medium than the control (data not shown). 
However, I did not have the time to establish whether CXCR6 signaling was important 
for IEL migration into the enteroids and for IEL intraepithelial movement. Further, it is 
possible that other chemokines, not just CXCR6, are involved.  
Blocking chemokines signaling with Pertussis toxin only partially inhibit IEL migration, 
indicated that there are other signalling pathways involve. Beside chemokine receptors, 





far functions of adhesion molecules on IEL have been shown to relate to IEL recruitment 
and retention to the epithelial layer. For example, β2 integrins involve in IEL homing and 
β7 integrins play a critical role in interactions between IELs and epithelial cells. Other 
surface adhesion molecules were upregulated in IELs when pre-treated with high 
concentration of IL-15 could contribute to the retention of IEL in the epithelium. The 
adhesion molecules I detected include L1CAM, PECAM-1, ICAM-2 and ALCAM. 
L1CAM is a neuronal cell adhesion molecule which plays a role in cell migration, cell 
adhesion and neuronal differentiation (Samatov, Wicklein et al. 2016). This protein is 
expressed not only on neuronal cells but also non-neuronal cells such as T cells, B cells 
and monocytes. PECAM-1 is highly expressed at endothelial cell-cell junctions and 
serves as an adhesive stress-response protein to maintain the endothelium integrity 
(Lertkiatmongkol, Liao et al. 2016). ICAM-2, intercellular adhesion molecule 2, is an 
endothelial ligand of LFA-1, together with ICAM-1 (Bargatze, Jutila et al. 1995). LFA-1 
(lymphocyte function associated antigen 1) is use by naïve lymphocytes to transmigrate 
into mucosal sites at the later step of the lymphocyte trafficking to the gut cascade 
(Springer 1994, Bargatze, Jutila et al. 1995). ICAM-2 is expressed at high levels on 
endothelium and mediates the LFA-1-dependant adhesion of lymphocytes to endothelial 
cells (Xu, Bickford et al. 1996, Lehmann, Jablonski-Westrich et al. 2003). Activated 
leukocyte cell adhesion molecules (ALCAM) interacts with its ligand, CD6 can activate 
T cells as co-stimulatory molecules (Hassan, Barclay et al. 2004). ALCAM also 
contributes to murine intestinal stem cell homeostasis by maintaining intestinal stem cell 
interactions with their niche (Smith, Davies et al. 2017). One noticeble among the 
upregulated proteins is JAML. JAML (Junctional Adhesion Molecule-Like) belongs to 
JAM transmembrane protein family that regulate cell-cell interactions and acts in 
neutrophil chemotaxis (Moog-Lutz, Cave-Riant et al. 2003, Zen, Liu et al. 2005). The 
interaction between JAML and its ligand, CAR (Coxsackievirus and adenovirus receptor) 
can mediate epithelial γδ T cell-specific activation and result in cellular proliferation, 
cytokine and growth factor generation (Witherden, Verdino et al. 2010). Therefore, its 
upregulation in IELs suggests a potential role for this protein in IEL survival within the 
epithelium. Vice versa, the downregulated adhesion molecules in pre-treated IELs which 
could imply the ability of IELs to be less adherent to IECs and move more freely within 
epithelium layer. Thus, changes in expression of adhesion molecules could also affect 
IEL interaction, migration to IECs and retention within epithelium. It would be interesting 





In addition, there have been several studies about γδ IELs but not αβ IELs migration in 
intestinal epithelial layer (Hoytema van Konijnenburg, Reis et al. 2017, Hu, Ethridge et 
al. 2018). From the proteomic data, there were some proteins only upregulated or 
downregulated in TCRαβ CD8αβ IELs but not in the other two populations. For example, 
CCR5 were downregulated in TCRγδ CD8αα IELs but strongly upregulated in TCRαβ 
CD8αβ IELs and TGF-β receptor type 1 expression was not found in ex vivo TCRαβ 
CD8αβ. It suggests that these conventional IELs subpopulation might migrate under 
different signalling, different movement patterns from TCRγδ IELs. Therefore, it would 
be interesting to compare TCRαβ IELs and other IEL subpopulations behaviours within 
the epithelium.   
In conclusion, my project has shown a sustainable co-culture between IEL and enteroids 
and that co-culture was a good model to study IEL intraepithelial movement as IELs were 
highly motile within enteroids. This movement was attenuated when the binding of IL-
15 with its receptors was inhibited, confirming a role for IL-15 in IEL kinetics. IL-15 
inhibition via IL-2Rβ blockade reduced IEL migratory patterns, however it is not clear 
whether it was because of reduce IEL survival or activation, or whether IL-2 contributed 
to IEL migration. Also it was not clear how much endogenous cytokines produced by 
enteroids contributed to IEL migration as the movement track was not be able to separate 
between inside and outside enteroids. One way in which IL-15 can regulate IEL migration 
is through the upregulation of CXCR6 expression. IELs express a high level of CXCR6 
and CXCL16 is the only known ligand for CXCR6, and I showed that IELs cultured with 
IL-15 migrated in response to the CXCL16 gradient. Treatment of the co-culture with 
Pertussis toxin showed a reduced migration of IEL into organoids. It suggests CXCR6 
and CXCL16 might involve in IEL recruitment and retention to intestinal epithelium. 
Other newly identified molecules are interesting as they all play important roles in other 
cell types. The identification of novel molecules that regulate IEL functions will provide 
targets for improving IEL surveillance of the gut. For example, in cancer or in vaccination 
strategies against pathogens. Conversly, these targets may also be important for the 









Materials and reagents 
 
1. IEL culture media 
Component Cat no. 
RPMI medium 31870-025 
FBS (10%) F7524 (Sigma) 
Pen/Strep 15140-122 
L-Glutamine 25030-024 
HEPES 25mM 17-737E 
Sodium Pyruvate 11360-070 
Non-essential acid amin (NEAA) 11140-035 
B-mercaptoethanol (100uM)  
 
2. IEL isolation media 
Component Cat no. 
RPMI medium 31870-025 




3. Crypt and organoid culture media 
3.1. Crypt media 
Component Cat no. 
Advanced DMEM/F12+++ 12634-010 
Pen/Strep 15140-122 
L-Glutamine 25030-024  
HEPES 27-737E 
B27 supplement 50X 12587-010 
N2 supplement 100X 400-163 
n-Acetylcysteine 500mM A9165-5G  
 
3.2. Organoid culture media 
Component Cat no. 
Crypt media  
Murine EGF 315-09 
Murine Noggin 250-38 
Murine R-spondin-1 315-32 
CHIR-99021 SML-1046 







4. L-WRN conditioned media preparation 
4.1. L-WRN cells media for thawing and expanding 
Component Cat no. 
DMEM High Glucose (Gibco) 11960-044 




4.2. L-WRN cells washing media 
Component Cat no. 
Advanced DMEM/F12  12634-010 
HEPES (15mM) 17-737E 




4.3. L-WRN primary media for cell collection and top-up  
Component Cat no. 
Advanced DMEM/F12 500mL 





















1. IEL isolation from mice 
The small intestine was dissected from mice with C57BL/6J background and 
GranzymeB-Cre-TdTomato and flushed with PBS, then was cut longitudinally and 
transversely to small 5 – 10mm pieces into warm IEL isolation medium (RPMI medium 
supplemented with 10% FBS, 5mL Pen/Strep and 5mL L-glutamine) with 1mM DTT 
(D5545-5G, Sigma-Aldrich). The tissue was incubated for 40 minutes in a shaker 
following by centrifugation at 500 x g for 5 minutes to remove the supernatant. 10mL 
warm IEL isolation medium was added and vortexed the tube for 3 minutes. The 
suspension was passed through a 100µm sieve (EASYstrainerTM, Greiner Bio-One). The 
tissues were collected and vortexed with another 10mL and further 30mL IEL isolation 
medium were added to wash the sieve. Subsequently, the content was centrifuged at 500 
x g for 5 minutes, and the pellet was resuspended in 5mL of 40% Percoll (diluted in PBS). 
Then the suspension was carefully added on top of 5mL 75% Percoll, following by 
centrifugation at 700 x g for 30 minutes with no brake. After centrifugation, IELs at the 
interface between two layers of Percoll were collected and washed with IEL culture 
medium (500mL RPMI supplemented with 10% FBS, 5mL Pen/Strep, 5mL L-glutamin, 
12.5mL HEPES, 5mL Sodium Pyruvate, 5mL Non-essential acid amin (NEAA), 1mL B-
mercaptoethanol (100µM)). 
2. Crypt isolation and culture 
A part of small intestine, about 5 – 7cm long, was dissected from WT mice (C57BL/6J). 
Crypts isolated from duodenum, jejunum and ileum can be used for organoid culture. In 
my study, I used duodenum part. The intestine was washed with cold PBS, cut 
longitudinally then spread open in a petri dish placed on ice. The villus was scraped off 
carefully using a coverslip. The intestine was cut into small 3 – 5mm pieces and 
transferred to 30mL of PBS with 1mM EDTA cooled on ice, then incubated for 20 
minutes at 4oC on a tube roller. After incubation, the content was passed through a 100µm 
sieve following by 30 minutes incubation with 30mL PBS with 5mM EDTA. The content 
was passed through the sieve again and the intestine was transfer to 10mL cold PBS. The 
tube was shaken vigorously for one minute. Observed the mixture to see the crypts and 
take 2mL to a new 15mL tube. The tube was centrifuged at 100 x g for 5 minutes, the 





DMEM/F12 (ADF) (500mL ADF; supplemented with 10% FBS, 5mL Pen/Strep, 5mL 
L-glutamine and 7.5mL 1M HEPES). 10µL was taken to count the number of crypts while 
centrifuging again. The pellet was resuspended in ADF to have about 50 – 100 crypts per 
50µL. The suspension was added into pre-thawed Matrigel (Corning, Cat no. 356231) 
with a ratio of 1:3 (suspension versus Matrigel), mixed thoroughly then 20µL was seeded 
at the centre of each well of a 24-well plate. The plate was incubated at 37oC for 10 – 15 
minutes for Matrigel polymerization before adding 500µL of organoid growth medium. 
Organoids were cultured at 37oC and 10% CO2 and fresh medium was changed every 2 – 
3 days. 
Organoids were passaged every 5 – 6 days, 1:2 or 1:3, depending on the number of 
organoids in each well and how dark the lumens were. 1mL of cold ADF were added in 
each well to dissociate the organoid and the suspension was centrifuged at 100 x g for 5 
mins. The pellet was resuspended in ADF before adding the suspension into Matrigel and 
plated it out. 
Growth medium used: 
 ENR: crypts medium supplemented with 50ng/mL EGF (PeproTech, 315-09), 
100ng/mL Noggin (PeproTech, 250-38) and 1µg/mL R-spondin-1 (PeproTech, 
315-32). For the first two days, 1µM CHIR-99021, Valproic acid and 10µM Y-
27632 is necessary to add in the medium (ENR-CVY). Prepared fresh in each 
experiment. Crypt medium: Advanced DMEM/F12 supplemented with 5mL 
Pen/Strep, 5 mL HEPES, 5mL L-glutamine,1 mL N-acetylcysteine, 5mL N2 
supplement, 10mL B27 supplement. 
 OGM: Organoid growth medium, purchased from Stem Cell Technologies (Cat no. 
#06005), a commercial medium. Aliquots were kept in the freezer, used within 2 
weeks after thawing. 
 Conditioned L-WRN media: harvested from L-WRN cells (ATCC® CRL-3276™) 
which are a source of Wnt3a, R-spondin-3 and Noggin. The cells were expanded 
and selected with Hygromycin B Gold and G418, then let the cells grew 
overconfluent for 3 to 4 days. Cells were washed then cultured with Primary media 
(Advanced DMEM/F12 supplemented with 20% FBS, 5mL Pen/Strep and 5mL L-
glutamine) for 24 hours. The medium was collected and centrifuged to get rid of 
dead cells. Conditioned L-WRN media was used at 50% dilution (Miyoshi and 





3. Cell culture of IEL 
IELs were enriched following an EasySep™ Mouse CD8α positive selection kit protocol 
from Stem Cell Technologies. Enriched IELs were then washed with IEL culture medium. 
These cells were seeded in a 96-well plate (U version) at 2×105 cells per well with 
100ng/mL Mouse IL-15R Complex Recombinant Protein (Life Technologies) for 
migration assays and flow cytometry.  
4. IEL-organoid co-culture 
IEL were isolated and enriched for CD8α cells following the method above. Two-day-
old organoids were collected by adding 1mL of cold ADF media in each well after 
removing the old medium. The Matrigel was dissociated carefully and collected into 
15mL tube. After centrifugation at 100 x g for 5 mins, the supernatant was discarded, and 
IELs were added into the tube at the ratio 1 crypts versus 500 IELs, 400µL of growth 
medium was added then incubated the mixture at 37oC for 30 minutes. After 30 minutes, 
the mixture was centrifuged at 100 x g for 3 minute. The supernatant was discarded, the 
pellet was resuspended in cold PBS and added to thawed Matrigel. 20µL of the mixture 
was seeded in a 24-well plate then the plate was incubated at 37oC for 10 – 15 minutes 
before adding the growth medium (supplemented with 10ng/mL soluble IL-15 and 100U 
IL-2). For confocal microscopy, the co-culture was seeded in a μ-Slide 8 well ibiTreat 
(Ibidi, Cat no. 80826). TM-β1 (BioLegend, Cat no. 123223) were added at the final 
concentration of 40µg/mL into medium at 48h and 1h before imaging. Medium was 
changed every 2 – 3 days.  
To block chemokine and G protein-coupled receptor signalling, 10ng/mL Pertussis toxin 
(Sigma-Aldrich, Cat no. 516560) was added in the medium when plating. 
Photos of the co-culture were taken by ZOE fluorescent cell imager (Bio-Rad). 
5. Live imaging 
Live imaging of co-culture was performed using Zeiss 710 Confocal Microscope system, 
objective 20X Dry. 20 Z-stacks of each region of interest (ROI) were acquired with an 
interval between each stack is 3µm. Data was analysed by Imaris and ImageJ (Fiji). For 
Imaris, IELs were tracked by creating a Spot function that detects cells with diameter 
from 7.5µm - 8µm. All data of each spot were exported. With ImageJ, TrackMate plug-





6. Migration assay 
IELs were isolated and sorted as previously described and put in culture with 100ng/mL 
IL-15Rα (Life Technologies) for 24 hours. At the day of experiment, the cells were 
collected and washed twice with IEL culture medium. Approximately 5×105 IELs were 
plated in the Corning® Transwell® polycarbonate membrane cell culture inserts (Sigma-
Aldrich, Cat no. CLS3421-48EA) with or without 100ng/mL IL-15Rα. 600µL medium 
supplemented with 10ng/mL CXCL16 (Novus) was added to the bottom chamber. The 
plate was incubated for 1.5 hours. Afterwards, Transwell inserts were removed, cells were 
collected at the bottom chamber and counted with LSR Fortessa by adding CountBright™ 
Absolute Counting Beads, for flow cytometry (ThermoFisher Scientific). 
7. Flow cytometry  
Cell were plated at 2×105 cells per well to a 96-well plate for staining. Fc block was added 
to each well for 5 minutes before cells were incubated with monoclonal antibodies against 
cell surface markers for 15 minutes covered on ice. Cells were stained with the following 
antibodies: CXCR6 [clone SA051D1 (BioLegend)], TCRβ [clone H57-597 
(BioLegend)], TCRγδ [clone GL3 (BioLegend)], CD8α [clone 53-6.7 (BioLegend)], 
CD8β [clone H35-17.2 (Invitrogen)]. Cells were then collected and resuspended in FACS 
buffer (PBS + 1% FBS). Data was acquired using a FACS LSR Fortessa flow cytometer 
with DIVA software (BD Bioscience) and analysed using FlowJo software (TreeStar). 
8. Mass spectrometry 
Sample preparation for mass spectrometry were previously described in (James, 
Vanderyken et al. 2020). Briefly, IELs were isolated as previously described and CD8α+ 
IEL population was enriched using an EasySep™ Release PE positive selection kit 
(STEMCELL Technologies) with a PE-conjugated anti-mouse CD8α antibody 
(BioLegend) following instructions from the manufacturer. TCRγδ CD8αα, TCRαβ 
CD8αα and TCRαβ CD8αα were purified by fluorescent activated cell sorting (FACS). 
Four biological replicates of each population were generated. IEL cell pellets were lysed 
in 200µl lysis buffer (4% SDS, 10mM TCEP, 50mM TEAB (pH 8.5)). Lysates were 
boiled and sonicated (15 cycles of 30s on/30s off) and protein concentrations determined 
by EZQ® Protein Quantitation Kit (Invitrogen). Lysates were alkylated with 
iodoacetamide (IAA) for one hour at room temperature in the dark. Proteins and peptide 
clean-up were performed according to Hughes et al., (2014). Samples were resuspended 





(Thermo Scientific). Samples were sent to MRC-PPU Mass Spectrometry facility, 
University of Dundee, where each fraction was analysed by label-free quantification 
(LFQ) using an LTQ OrbiTrap Velos Pro (Thermo Scientific) with a 240-minute gradient 
per fraction. 
9. Statistics 
All statistics was performed using Graphpad prism 8. Data was presented with mean ± 
SD or with a 95% confidence interval. Data was analysed using one-way ANOVA with 

















Table 1: Upregulated and downregulated proteins by IL-15 
  Protein names Functions 
Upregulated 





Chemokine (C-C motif) receptor 5 
(CCR5)       
Chemokine (C-C motif) receptor 9 
(CCR9)         
Chemokine (C-X-C motif) receptor 6 
(CXCR6)     
Adhesion G protein-coupled receptor 
G5(Adgrg5)       
G-protein coupled 
receptor, GPCR signaling 
pathway, GPCR activity 
G protein-coupled receptor 132 (Gpr132)    
G protein-coupled receptor 171 (Gpr171)  
G protein-coupled receptor 55 (Gpr55)       
G-protein coupled receptor 65 (Gpr65)      
G protein-coupled receptor 18 (Gpr18) 
ATP-binding cassette, sub-family A 
(ABC1), member 7 (Abca7)           




Adhesion molecule, interacts with 
CXADR antigen 1 (Amica1/JAML)   
Transforming growth factor, beta receptor 
I (Tgfbr1)        
Desmoglein 1 alpha (Dsg1a)    
Platelet/endothelial cell adhesion 
molecule 1(Pecam1) 
Desmoglein 1 beta (Dsg1b)    
Integrin alpha 3 (Itga3)   
Embigin(Emb)  (only in TCRabCD8ab) 
Dystroglycan 1 (Dag1)       
Activated leukocyte cell adhesion 
molecule (Alcam) 
L1 cell adhesion molecule(L1cam) 
Downregulated 
Desmoglein 1 alpha (Dsg1a)   
Cell adhesion, cadherin-
binding involved in cell 
adhesion 
Desmoglein 1 beta (Dsg1b)   
Claudin 23 (Cldn23)       
Integrin alpha M (Itgam)   
Cadherin 17 (Cdh17)      
G-protein coupled receptor 65(Gpr65)       
G-protein coupled 
receptor, GPCR signaling 
pathway, GPCR activity 




































CXCR6 2.67 4.18 4.32 
CXCR3 1.17 3.13 1.13 
CCR5 0.35 4.74 0.00 
CCR9 1.25 5.87 1.50 
Adhesion 
molecules 
ALCAM 2.17 3.26 1.25 
PECAM-
1 4.69 1.26 1.70 
ICAM-2 2.02 3.39 2.70 
L1CAM 3.98 3.84 4.31 
Activating 
receptors 
JAML 8.62 19.60 17.12 




Cdh17 0.14 1.93 0.29 
ItgaM 0.45 1.50 0.92 








1. Agace, W. W., et al. (2000). "Human intestinal lamina propria and intraepithelial 
lymphocytes express receptors specific for chemokines induced by inflammation." 
Eur J Immunol 30(3): 819-826. 
2. Bargatze, R. F., et al. (1995). "Distinct roles of L-selectin and integrins alpha 4 beta 
7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep 
model confirmed and refined." Immunity 3(1): 99-108. 
3. Bauche, D. and J. C. Marie (2017). "Transforming growth factor beta: a master 
regulator of the gut microbiota and immune cell interactions." Clin Transl 
Immunology 6(4): e136. 
4. Bauer, S., et al. (1999). "Activation of NK cells and T cells by NKG2D, a receptor 
for stress-inducible MICA." Science 285(5428): 727-729. 
5. Beagley, K. W., et al. (1995). "Differences in intraepithelial lymphocyte T cell 
subsets isolated from murine small versus large intestine." J Immunol 154(11): 5611-
5619. 
6. Boismenu, R. and W. L. Havran (1994). "Modulation of epithelial cell growth by 
intraepithelial gamma delta T cells." Science 266(5188): 1253-1255. 
7. Bottino, C., et al. (2003). "Identification of PVR (CD155) and Nectin-2 (CD112) as 
cell surface ligands for the human DNAM-1 (CD226) activating molecule." J Exp 
Med 198(4): 557-567. 
8. Brogden, K. A. (2005). "Antimicrobial peptides: pore formers or metabolic inhibitors 
in bacteria?" Nat Rev Microbiol 3(3): 238-250. 
9. Butcher, M. J., et al. (2016). "CXCR6 regulates the recruitment of pro-inflammatory 
IL-17A-producing T cells into atherosclerotic aortas." Int Immunol 28(5): 255-261. 
10. Cash, H. L., et al. (2006). "Symbiotic bacteria direct expression of an intestinal 
bactericidal lectin." Science 313(5790): 1126-1130. 
11. Cepek, K. L., et al. (1994). "Adhesion between epithelial cells and T lymphocytes 
mediated by E-cadherin and the alpha E beta 7 integrin." Nature 372(6502): 190-193. 
12. Chang, Y. Y., et al. (2018). "Deletion of cadherin-17 enhances intestinal permeability 
and susceptibility to intestinal tumour formation." J Pathol 246(3): 289-299. 
13. Chea, S., et al. (2015). "CXCR6 Expression Is Important for Retention and 





14. Chennupati, V., et al. (2010). "Intra- and intercompartmental movement of 
gammadelta T cells: intestinal intraepithelial and peripheral gammadelta T cells 
represent exclusive nonoverlapping populations with distinct migration 
characteristics." J Immunol 185(9): 5160-5168. 
15. Cheroutre, H., et al. (2011). "The light and dark sides of intestinal intraepithelial 
lymphocytes." Nat Rev Immunol 11(7): 445-456. 
16. Darash-Yahana, M., et al. (2009). "The chemokine CXCL16 and its receptor, 
CXCR6, as markers and promoters of inflammation-associated cancers." PLoS One 
4(8): e6695. 
17. Dignass, A. U. and A. Sturm (2001). "Peptide growth factors in the intestine." Eur J 
Gastroenterol Hepatol 13(7): 763-770. 
18. Du, X., et al. (2018). "CD226 regulates natural killer cell antitumor responses via 
phosphorylation-mediated inactivation of transcription factor FOXO1." Proc Natl 
Acad Sci U S A 115(50): E11731-E11740. 
19. Edelblum, K. L., et al. (2012). "Dynamic migration of gammadelta intraepithelial 
lymphocytes requires occludin." Proc Natl Acad Sci U S A 109(18): 7097-7102. 
20. Edelblum, K. L., et al. (2015). "gammadelta Intraepithelial Lymphocyte Migration 
Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice." 
Gastroenterology 148(7): 1417-1426. 
21. Frisch, S. M. and H. Francis (1994). "Disruption of epithelial cell-matrix interactions 
induces apoptosis." J Cell Biol 124(4): 619-626. 
22. Gewirtz, A. T., et al. (2001). "Cutting edge: bacterial flagellin activates basolaterally 
expressed TLR5 to induce epithelial proinflammatory gene expression." J Immunol 
167(4): 1882-1885. 
23. Gilder, A. S., et al. (2016). "Pertussis Toxin Is a Robust and Selective Inhibitor of 
High Grade Glioma Cell Migration and Invasion." PLoS One 11(12): e0168418. 
24. Gorfu, G., et al. (2009). "Role of beta7 integrins in intestinal lymphocyte homing and 
retention." Curr Mol Med 9(7): 836-850. 
25. Groom, J. R. and A. D. Luster (2011). "CXCR3 in T cell function." Exp Cell Res 
317(5): 620-631. 
26. Hald, S. M., et al. (2015). "Prognostic impact of CXCL16 and CXCR6 in non-small 
cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer 





27. Hall, P. A., et al. (1994). "Regulation of cell number in the mammalian 
gastrointestinal tract: the importance of apoptosis." J Cell Sci 107 (Pt 12): 3569-3577. 
28. Haramis, A. P., et al. (2004). "De novo crypt formation and juvenile polyposis on 
BMP inhibition in mouse intestine." Science 303(5664): 1684-1686. 
29. Haskell, C. A., et al. (1999). "Molecular uncoupling of fractalkine-mediated cell 
adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is 
independent of G-protein activation." J Biol Chem 274(15): 10053-10058. 
30. Hassan, N. J., et al. (2004). "Frontline: Optimal T cell activation requires the 
engagement of CD6 and CD166." Eur J Immunol 34(4): 930-940. 
31. Heesch, K., et al. (2014). "The function of the chemokine receptor CXCR6 in the T 
cell response of mice against Listeria monocytogenes." PLoS One 9(5): e97701. 
32. Hoytema van Konijnenburg, D. P., et al. (2017). "Intestinal Epithelial and 
Intraepithelial T Cell Crosstalk Mediates a Dynamic Response to Infection." Cell 
171(4): 783-794 e713. 
33. Hu, M. D., et al. (2018). "Epithelial IL-15 Is a Critical Regulator of gammadelta 
Intraepithelial Lymphocyte Motility within the Intestinal Mucosa." J Immunol 
201(2): 747-756. 
34. Hu, M. D., et al. (2018). "Policing the intestinal epithelial barrier: Innate immune 
functions of intraepithelial lymphocytes." Curr Pathobiol Rep 6(1): 35-46. 
35. Imai, T., et al. (1997). "Identification and molecular characterization of fractalkine 
receptor CX3CR1, which mediates both leukocyte migration and adhesion." Cell 
91(4): 521-530. 
36. Inagaki-Ohara, K., et al. (1997). "Potential for involvement of Fas antigen/Fas ligand 
interaction in apoptosis of epithelial cells by intraepithelial lymphocytes in murine 
small intestine." Lab Invest 77(5): 421-429. 
37. James, O. J., et al. (2020). "Comprehensive proteomics analyses identify PIM kinases 
as key regulators of IL-15 driven activation of intestinal intraepithelial lymphocytes." 
bioRxiv: 2020.2003.2027.011338. 
38. Karin, M. and H. Clevers (2016). "Reparative inflammation takes charge of tissue 
regeneration." Nature 529(7586): 307-315. 
39. Koenen, A., et al. (2017). "The DRF motif of CXCR6 as chemokine receptor 
adaptation to adhesion." PLoS One 12(3): e0173486. 
40. Konkel, J. E. and W. Chen (2011). "Balancing acts: the role of TGF-beta in the 





41. Kurokowa, M., et al. (1987). "Effects of growth factors on an intestinal epithelial cell 
line: transforming growth factor beta inhibits proliferation and stimulates 
differentiation." Biochem Biophys Res Commun 142(3): 775-782. 
42. Langlands, A. J., et al. (2016). "Paneth Cell-Rich Regions Separated by a Cluster of 
Lgr5+ Cells Initiate Crypt Fission in the Intestinal Stem Cell Niche." PLoS Biol 
14(6): e1002491. 
43. Lehmann, J. C., et al. (2003). "Overlapping and selective roles of endothelial 
intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 in lymphocyte 
trafficking." J Immunol 171(5): 2588-2593. 
44. Lertkiatmongkol, P., et al. (2016). "Endothelial functions of platelet/endothelial cell 
adhesion molecule-1 (CD31)." Curr Opin Hematol 23(3): 253-259. 
45. Lodolce, J. P., et al. (1998). "IL-15 receptor maintains lymphoid homeostasis by 
supporting lymphocyte homing and proliferation." Immunity 9(5): 669-676. 
46. Lu, Y., et al. (2008). "CXCL16 functions as a novel chemotactic factor for prostate 
cancer cells In vitro." Mol Cancer Res 6(4): 546-554. 
47. Luangsay, S., et al. (2003). "CCR5 mediates specific migration of Toxoplasma 
gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells." 
Gastroenterology 125(2): 491-500. 
48. Luo, Y., et al. (2002). "RANTES stimulates inflammatory cascades and receptor 
modulation in murine astrocytes." Glia 39(1): 19-30. 
49. Ma, L. J., et al. (2009). "Trans-presentation of IL-15 by intestinal epithelial cells 
drives development of CD8alphaalpha IELs." J Immunol 183(2): 1044-1054. 
50. Mabbott, N. A., et al. (2013). "Microfold (M) cells: important immunosurveillance 
posts in the intestinal epithelium." Mucosal Immunol 6(4): 666-677. 
51. Matloubian, M., et al. (2000). "A transmembrane CXC chemokine is a ligand for 
HIV-coreceptor Bonzo." Nat Immunol 1(4): 298-304. 
52. Matsumura, S., et al. (2008). "Radiation-induced CXCL16 release by breast cancer 
cells attracts effector T cells." J Immunol 181(5): 3099-3107. 
53. Miyoshi, H. and T. S. Stappenbeck (2013). "In vitro expansion and genetic 
modification of gastrointestinal stem cells in spheroid culture." Nat Protoc 8(12): 
2471-2482. 
54. Moog-Lutz, C., et al. (2003). "JAML, a novel protein with characteristics of a 
junctional adhesion molecule, is induced during differentiation of myeloid leukemia 





55. Moratz, C., et al. (2004). "Role of RGS proteins in regulating the migration of B 
lymphocytes." Arch Immunol Ther Exp (Warsz) 52(1): 27-35. 
56. Moss J, Stanley SJ, Burns DL, Hsia JA, Yost DA, Myers GA & Hewlett EL (1983) 
“Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase 
activities of Bordetella pertussis toxin (islet-activating protein).” J Biol Chem 258, 
11879–11882. 
57. Muehlhoefer, A., et al. (2000). "Fractalkine is an epithelial and endothelial cell-
derived chemoattractant for intraepithelial lymphocytes in the small intestinal 
mucosa." J Immunol 164(6): 3368-3376. 
58. Muniz, L. R., et al. (2012). "Intestinal antimicrobial peptides during homeostasis, 
infection, and disease." Front Immunol 3: 310. 
59. Nozaki, K., et al. (2016). "Co-culture with intestinal epithelial organoids allows 
efficient expansion and motility analysis of intraepithelial lymphocytes." J 
Gastroenterol 51(3): 206-213. 
60. Okumura, R. and K. Takeda (2017). "Roles of intestinal epithelial cells in the 
maintenance of gut homeostasis." Exp Mol Med 49(5): e338. 
61. Papadakis, K. A. and S. R. Targan (2000). "Role of cytokines in the pathogenesis of 
inflammatory bowel disease." Annu Rev Med 51: 289-298. 
62. Peterson, L. W. and D. Artis (2014). "Intestinal epithelial cells: regulators of barrier 
function and immune homeostasis." Nat Rev Immunol 14(3): 141-153. 
63. Pinto, D., et al. (2003). "Canonical Wnt signals are essential for homeostasis of the 
intestinal epithelium." Genes Dev 17(14): 1709-1713. 
64. Reif, K. and J. G. Cyster (2000). "RGS molecule expression in murine B lymphocytes 
and ability to down-regulate chemotaxis to lymphoid chemokines." J Immunol 
164(9): 4720-4729. 
65. Samatov, T. R., et al. (2016). "L1CAM: Cell adhesion and more." Prog Histochem 
Cytochem 51(2): 25-32. 
66. Sasaki, T., et al. (2002). "Expression and distribution of laminin alpha1 and alpha2 
chains in embryonic and adult mouse tissues: an immunochemical approach." Exp 
Cell Res 275(2): 185-199. 
67. Sato, T., et al. (2009). "Single Lgr5 stem cells build crypt-villus structures In vitro 
without a mesenchymal niche." Nature 459(7244): 262-265. 
68. Schon, M. P., et al. (1999). "Mucosal T lymphocyte numbers are selectively reduced 





69. Serra, D., et al. (2019). "Self-organization and symmetry breaking in intestinal 
organoid development." Nature 569(7754): 66-72. 
70. Shaw, S. K., et al. (1998). "Migration of intestinal intraepithelial lymphocytes into a 
polarized epithelial monolayer." Am J Physiol 275(3): G584-591. 
71. Sheridan, B. S. and L. Lefrancois (2010). "Intraepithelial lymphocytes: to serve and 
protect." Curr Gastroenterol Rep 12(6): 513-521. 
72. Shibuya, A., et al. (1996). "DNAM-1, a novel adhesion molecule involved in the 
cytolytic function of T lymphocytes." Immunity 4(6): 573-581. 
73. Shires, J., et al. (2001). "Biological insights into TCRgammadelta+ and 
TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene 
expression (SAGE)." Immunity 15(3): 419-434. 
74. Smith, N. R., et al. (2017). "Cell Adhesion Molecule CD166/ALCAM Functions 
Within the Crypt to Orchestrate Murine Intestinal Stem Cell Homeostasis." Cell Mol 
Gastroenterol Hepatol 3(3): 389-409. 
75. Spangrude, G. J., et al. (1985). "Inhibition of lymphocyte and neutrophil chemotaxis 
by pertussis toxin." J Immunol 135(6): 4135-4143. 
76. Springer, T. A. (1994). "Traffic signals for lymphocyte recirculation and leukocyte 
emigration: the multistep paradigm." Cell 76(2): 301-314. 
77. Stingl, J., et al. (2001). "Characterization of bipotent mammary epithelial progenitor 
cells in normal adult human breast tissue." Breast Cancer Res Treat 67(2): 93-109. 
78. Strauch, U. G., et al. (2001). "Integrin alpha E(CD103)beta 7 mediates adhesion to 
intestinal microvascular endothelial cell lines via an E-cadherin-independent 
interaction." J Immunol 166(5): 3506-3514. 
79. Sumida, H., et al. (2017). "GPR55 regulates intraepithelial lymphocyte migration 
dynamics and susceptibility to intestinal damage." Sci Immunol 2(18). 
80. Suzuki, H., et al. (1997). "Abnormal development of intestinal intraepithelial 
lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta 
chain." J Exp Med 185(3): 499-505. 
81. Tahara-Hanaoka, S., et al. (2004). "Functional characterization of DNAM-1 (CD226) 
interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)." Int 
Immunol 16(4): 533-538. 
82. Tinevez, JY.; Perry, N. & Schindelin, J. et al. (2017), "TrackMate: An open and 
extensible platform for single-particle tracking.", Methods 115: 80-90, PMID 





83. Ting, H. A. and J. von Moltke (2019). "The Immune Function of Tuft Cells at Gut 
Mucosal Surfaces and Beyond." J Immunol 202(5): 1321-1329. 
84. Tse, S. W., et al. (2014). "The chemokine receptor CXCR6 is required for the 
maintenance of liver memory CD8(+) T cells specific for infectious pathogens." J 
Infect Dis 210(9): 1508-1516. 
85. Uehara, S., et al. (2002). "A role for CCR9 in T lymphocyte development and 
migration." J Immunol 168(6): 2811-2819. 
86. Vaishnava, S., et al. (2011). "The antibacterial lectin RegIIIgamma promotes the 
spatial segregation of microbiota and host in the intestine." Science 334(6053): 255-
258. 
87. van der Flier, L. G. and H. Clevers (2009). "Stem cells, self-renewal, and 
differentiation in the intestinal epithelium." Annu Rev Physiol 71: 241-260. 
88. Van Kaer, L. and D. Olivares-Villagomez (2018). "Development, Homeostasis, and 
Functions of Intestinal Intraepithelial Lymphocytes." J Immunol 200(7): 2235-2244. 
89. von Moltke, J., et al. (2016). "Tuft-cell-derived IL-25 regulates an intestinal ILC2-
epithelial response circuit." Nature 529(7585): 221-225. 
90. Wang, X., et al. (2014). "GPR18 is required for a normal CD8alphaalpha intestinal 
intraepithelial lymphocyte compartment." J Exp Med 211(12): 2351-2359. 
91. Wein, A. N., et al. (2019). "CXCR6 regulates localization of tissue-resident memory 
CD8 T cells to the airways." J Exp Med 216(12): 2748-2762. 
92. Wendeler, M. W., et al. (2007). "Intestinal LI-cadherin acts as a Ca2+-dependent 
adhesion switch." J Mol Biol 370(2): 220-230. 
93. Witherden, D. A., et al. (2010). "The junctional adhesion molecule JAML is a 
costimulatory receptor for epithelial gammadelta T cell activation." Science 
329(5996): 1205-1210. 
94. Wurbel, M. A., et al. (2001). "Mice lacking the CCR9 CC-chemokine receptor show 
a mild impairment of early T- and B-cell development and a reduction in T-cell 
receptor gammadelta(+) gut intraepithelial lymphocytes." Blood 98(9): 2626-2632. 
95. Xu, H., et al. (1996). "Characterization of murine intercellular adhesion molecule-2." 
J Immunol 156(12): 4909-4914. 
96. Yu, Y., et al. (2003). "TLR5-mediated activation of p38 MAPK regulates epithelial 
IL-8 expression via posttranscriptional mechanism." Am J Physiol Gastrointest Liver 





97. Zaid, A., et al. (2017). "Chemokine Receptor-Dependent Control of Skin Tissue-
Resident Memory T Cell Formation." J Immunol 199(7): 2451-2459. 
98. Zen, K., et al. (2005). "Neutrophil migration across tight junctions is mediated by 
adhesive interactions between epithelial coxsackie and adenovirus receptor and a 
junctional adhesion molecule-like protein on neutrophils." Mol Biol Cell 16(6): 
2694-2703. 
 
